Singapore Confirms Case of Acute Hepatitis in 10-Month Old Baby
(Bloomberg) -- Singapore confirmed a case of acute hepatitis in a 10-month old baby and is investigating to see if it has a similar presentation to other cases of the liver inflammation illness reported around the world.
Laboratory testing has determined the case to be negative for the common viruses that cause hepatitis -- type A, B, C and E viruses -- the city state's Ministry of Health said in an emailed statement. The baby has a previous history of Covid-19 in December, although there's no current evidence that the acute hepatitis is related to coronavirus.
An outbreak in children of acute hepatitis has killed at least one and required liver transplants in more than a dozen others across the globe, according to the World Health Organization. While the cause is undetermined, investigators are studying a family of pathogens, called adenoviruses, that cause a range of illnesses including the common cold.
As of April 21, 169 cases had been detected, the WHO has said. Most of them were in the U.K., as well as some in countries including Spain, Israel, the U.S. and other nations in Europe. Japan also has said it found some probable cases this week.
U.S. health officials have cast doubt on Covid-19 as a potential cause of the severe hepatitis cases, while adding weight to the possibility that they may be caused by the more common virus linked to stomach ailments.
Read More: What We Know About the Mysterious Liver Disease Hurting Children
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.